901 related articles for article (PubMed ID: 17218233)
21. Resectoscopic surgery in women with abnormal uterine bleeding and nonatypical endometrial hyperplasia.
Vilos GA; Harding PG; Ettler HC
J Am Assoc Gynecol Laparosc; 2002 May; 9(2):131-7. PubMed ID: 11960036
[TBL] [Abstract][Full Text] [Related]
22. Endometrial hydrothermablation: a comparison of short-term clinical effectiveness in patients with normal endometrial cavities and those with intracavitary pathology.
Rosenbaum SP; Fried M; Munro MG
J Minim Invasive Gynecol; 2005; 12(2):144-9. PubMed ID: 15904618
[TBL] [Abstract][Full Text] [Related]
23. Five-year follow-up of patients with recurrent postmenopausal bleeding.
Twu NF; Chen SS
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):628-33. PubMed ID: 10969449
[TBL] [Abstract][Full Text] [Related]
24. The levonorgestrel intrauterine system is an effective treatment in women with abnormal uterine bleeding and anticoagulant therapy.
Vilos GA; Tureanu V; Garcia M; Abu-Rafea B
J Minim Invasive Gynecol; 2009; 16(4):480-4. PubMed ID: 19573825
[TBL] [Abstract][Full Text] [Related]
25. The diagnosis of endometrial hyperplasia on curettage: how reliable is it?
Obeidat B; Mohtaseb A; Matalka I
Arch Gynecol Obstet; 2009 Apr; 279(4):489-92. PubMed ID: 18679697
[TBL] [Abstract][Full Text] [Related]
26. Polypectomy in premenopausal women with abnormal uterine bleeding: effectiveness of hysteroscopic removal.
Henriquez DD; van Dongen H; Wolterbeek R; Jansen FW
J Minim Invasive Gynecol; 2007; 14(1):59-63. PubMed ID: 17218231
[TBL] [Abstract][Full Text] [Related]
27. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps.
Lieng M; Qvigstad E; Sandvik L; Jørgensen H; Langebrekke A; Istre O
J Minim Invasive Gynecol; 2007; 14(2):189-94. PubMed ID: 17368255
[TBL] [Abstract][Full Text] [Related]
28. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
Mittal K; Da Costa D
Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
[TBL] [Abstract][Full Text] [Related]
29. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
30. [Atypical endometrial hyperplasia. Prognosis and course].
Jensen HH; Hussain SF; Pedersen PH; Andreasson B
Ugeskr Laeger; 2000 Jan; 162(5):666-9. PubMed ID: 10707601
[TBL] [Abstract][Full Text] [Related]
31. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
[TBL] [Abstract][Full Text] [Related]
32. Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia.
Bilgin T; Ozuysal S; Ozan H; Atakan T
J Obstet Gynaecol Res; 2004 Jun; 30(3):205-9. PubMed ID: 15210044
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
Lindahl B; Willén R
Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
[TBL] [Abstract][Full Text] [Related]
34. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
35. Outcome of repeated hysteroscopic resection of the endometrium.
Hansen BB; Dreisler E; Stampe Sørensen S
J Minim Invasive Gynecol; 2008; 15(6):704-6. PubMed ID: 18774760
[TBL] [Abstract][Full Text] [Related]
36. Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction.
Ørbo A; Kaino T; Arnes M; Larsen K; Pettersen I; Moe B
Acta Obstet Gynecol Scand; 2009; 88(11):1234-42. PubMed ID: 19900140
[TBL] [Abstract][Full Text] [Related]
37. [Hysteroscopic endometrial reduction. Analysis of 85 cases].
Luneau F; Boubli L; Nadal F; Bautrant E; Blanc B
Rev Fr Gynecol Obstet; 1992 May; 87(5):260-6. PubMed ID: 1626171
[TBL] [Abstract][Full Text] [Related]
38. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
[TBL] [Abstract][Full Text] [Related]
39. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.
Eddib A; Allaf B; Lee J; Yeh J
Gynecol Obstet Invest; 2012; 73(1):38-42. PubMed ID: 22056948
[TBL] [Abstract][Full Text] [Related]
40. Operative treatment of endometrial hyperplasia in kidney graft recipients: report of seven cases.
Bobrowska K; Pietrzak B; Jabiry-Zieniewicz Z; Cyganek A; Kaminski P; Wielgos M; Durlik M
Transplant Proc; 2007 Nov; 39(9):2756-8. PubMed ID: 18021979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]